Oxigene Inc (NASDAQ:OXGN)

CAPS Rating: 1 out of 5

A biotechnology company developing novel small-molecule therapeutics to treat cancer and eye diseases.

Recs

0
Player Avatar pchop123 (76.56) Submitted: 7/1/2012 9:35:23 PM : Outperform Start Price: $6.72 OXGN Score: -3.29

Watch this one get UP and run !!!

Report this Post Reply

Featured Broker Partners


Advertisement